Suven Life Sciences’ net profit in Q3 dips 27%

06 Feb 2019 Evaluate

Suven Life Sciences has reported results for third quarter ended December 31, 2018.

The company has reported 27.08% fall in its net profit at Rs 25.23 crore for the quarter under review as compared to Rs 34.60 crore for the same quarter in the previous year. Total income of the company decreased by 19.27% at Rs 134.78 crore for Q3FY19 as compared Rs 166.95 crore for the corresponding quarter previous year.

Suven Life Sciences is a biopharmaceutical company focused on discovering, developing and commercializing novel pharmaceutical products, which are first in class or best in class CNS therapies using GPCR targets.

Suven Life Sciences Share Price

170.15 -1.25 (-0.73%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×